Notice of NIDA Participation in RFA-OD-18-004 "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)"

Notice Number: NOT-DA-18-009

Key Dates
Release Date: March 12, 2018

Related Announcements
RFA-OD-18-004

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

he purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) will participate, effective immediately, in the Funding Opportunity Announcement (FOA) RFA-OD-18-004, "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54)". NIDA’s commitment of funds decision will be made following peer review of the applications.


The following sections of RFA-OD-18-004 have been updated to reflect the participation of NIDA in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

The following information has been added:

Components of Participating Organizations
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.279

Part 2. Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s)
Cora Lee Wetherington, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1319
Email: cwetheri@nida.nih.gov


Financial/Grants Management Contact(s)
Pam Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: pfleming@nida.nih.gov

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Cora Lee Wetherington, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1319
Email: cwetheri@nida.nih.gov